Argyle Capital Management Inc. Johnson & Johnson Transaction History

Argyle Capital Management Inc.

$285 Million
Q3 2025

A detailed history of Argyle Capital Management Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Argyle Capital Management Inc. holds 25,904 shares of JNJ stock, worth $5.17 Million. This represents 1.69% of its overall portfolio holdings.

Number of Shares

25,904

Previous 25,904 -0.0%

Holding current value

$5.17 Million

Previous $3.96 Million 21.41%

% of portfolio

1.69%

Previous 1.46%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 24, 2025	SELL	$146.36 - $159.82 $14,636 - $15,982	-100 Reduced 0.38%	25,904 $3.96 Million
Q1 2025 Apr 29, 2025	BUY	$142.06 - $167.7 $28,412 - $33,540	200 Added 0.78%	26,004 $4.31 Million
Q4 2024 Feb 05, 2025	BUY	$143.34 - $165.86 $241,097 - $278,976	1,682 Added 6.97%	25,804 $3.73 Million
Q3 2024 Oct 25, 2024	SELL	$145.48 - $167.38 $95,143 - $109,466	-654 Reduced 2.64%	24,122 $3.91 Million
Q2 2024 Jul 29, 2024	BUY	$144.38 - $157.78 $142,214 - $155,413	985 Added 4.14%	24,776 $3.62 Million

Q1 2024 Apr 29, 2024	BUY	$155.22 - $162.74 $93,132 - $97,644	600 Added 2.59%	23,791 $3.76 Million
Q4 2023 Feb 05, 2024	SELL	$145.6 - $158.88 $731,640 - $798,372	-5,025 Reduced 17.81%	23,191 $3.63 Million
Q2 2023 Jul 27, 2023	SELL	$154.35 - $166.11 $317,497 - $341,688	-2,057 Reduced 6.79%	28,216 $4.67 Million
Q4 2022 Feb 06, 2023	SELL	$160.2 - $179.79 $16,019 - $17,979	-100 Reduced 0.33%	30,273 $5.35 Million
Q1 2022 Apr 27, 2022	SELL	$158.14 - $179.59 $142,326 - $161,631	-900 Reduced 2.88%	30,373 $5.38 Million
Q4 2021 Jan 25, 2022	SELL	$155.93 - $173.01 $116,947 - $129,757	-750 Reduced 2.34%	31,273 $5.35 Million
Q3 2021 Oct 25, 2021	SELL	$161.5 - $179.47 $28,262 - $31,407	-175 Reduced 0.54%	32,023 $5.17 Million
Q2 2021 Jul 27, 2021	SELL	$159.48 - $171.07 $37,158 - $39,859	-233 Reduced 0.72%	32,198 $5.3 Million
Q1 2021 Apr 27, 2021	SELL	$153.07 - $170.48 $11,480 - $12,786	-75 Reduced 0.23%	32,431 $5.33 Million
Q4 2020 Jan 28, 2021	SELL	$137.11 - $157.38 $174,815 - $200,659	-1,275 Reduced 3.77%	32,506 $5.12 Million
Q3 2020 Oct 27, 2020	SELL	$140.38 - $153.83 $173,650 - $190,287	-1,237 Reduced 3.53%	33,781 $5.03 Million
Q3 2019 Oct 25, 2019	BUY	$126.95 - $142.14 $6,347 - $7,106	50 Added 0.14%	35,018 $4.53 Million
Q2 2019 Jul 25, 2019	SELL	$131.15 - $144.24 $91,805 - $100,968	-700 Reduced 1.96%	34,968 $4.87 Million
Q4 2018 Jan 28, 2019	BUY	$122.84 - $147.84 $5,650 - $6,800	46 Added 0.13%	35,668 $4.6 Million
Q2 2018 Aug 14, 2018	BUY	$119.4 - $131.76 $355,453 - $392,249	2,977 Added 9.12%	35,622 $4.32 Million
Q1 2018 Apr 25, 2018	SELL	$125.1 - $148.14 $137,610 - $162,953	-1,100 Reduced 3.26%	32,645 $4.18 Million
Q4 2017 Jan 25, 2018	SELL	$131.22 - $143.62 $15,090 - $16,516	-115 Reduced 0.34%	33,745 $4.72 Million
Q3 2017 Oct 26, 2017	BUY	$129.47 - $135.38 $4.38 Million - $4.58 Million	33,860	33,860 $4.4 Million

Others Institutions Holding JNJ

# of Institutions

4,865

Shares Held

1.74B

Call Options Held

19.8M

Put Options Held

16.8M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $522B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Argyle Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Argyle Capital Management Inc. with notifications on news.

Account

Argyle Capital Management Inc. Johnson & Johnson Transaction History